SICKLE CELL ANEMIA

PRERNA FOR IAS

SICKLE CELL ANEMIA

1. Inherited Disorder (Genetic)

Sickle Cell Anemia is an inherited genetic blood disorder caused by a mutation in the HBB gene, which produces abnormal haemoglobin known as Haemoglobin S (HbS). It follows an autosomal recessive pattern of inheritance, meaning a child must inherit the defective gene from both parents to develop the disease. If only one mutated gene is inherited, the person is called a carrier (Sickle Cell Trait) and usually has no major symptoms. The disease is more common among people of African, Mediterranean, Middle Eastern, and Indian ancestry, especially in tribal populations of India.

2. Affects Red Blood Cells (RBCs)

Sickle Cell Anemia primarily affects red blood cells (RBCs), which carry oxygen throughout the body using haemoglobin. In healthy individuals, RBCs are round, soft, and flexible, allowing them to move easily through blood vessels. In this disease, abnormal haemoglobin causes RBCs to become sickle-shaped (crescent-shaped) under low oxygen conditions. These abnormal cells are rigid, sticky, and fragile, making it difficult for them to pass through small blood vessels. As a result, oxygen delivery to tissues is reduced, leading to pain, organ damage, and various health complications over time.

3. No Cure

Currently, there is no universal cure for Sickle Cell Anemia, although treatments can effectively manage symptoms and improve quality of life. Medicines such as hydroxyurea, pain relievers, antibiotics, blood transfusions, and supportive care help reduce complications. In some cases, bone marrow or stem cell transplantation may offer a potential cure, but it is suitable only for selected patients. Early diagnosis, regular medical follow-up, vaccination, proper nutrition, and infection prevention significantly improve survival and overall health. Ongoing research, including gene therapy, offers hope for safer and more effective treatments in the future.

4. Normal Red Blood Cells

Normal red blood cells are round, biconcave, flexible, and elastic, allowing them to move smoothly through even the smallest blood vessels. They contain normal haemoglobin that efficiently carries oxygen from the lungs to all parts of the body and returns carbon dioxide to the lungs for removal. Healthy RBCs survive for about 120 days before being replaced by new cells produced in the bone marrow. Their flexibility ensures uninterrupted blood circulation and proper oxygen supply to tissues. Efficient functioning of normal RBCs is essential for maintaining energy levels, organ function, and overall health.

5. Disordered Red Blood Cells

In Sickle Cell Anemia, red blood cells become crescent or sickle-shaped because of abnormal haemoglobin. These sickle cells are hard, sticky, and less flexible than normal RBCs. They tend to block small blood vessels, reducing blood flow and oxygen delivery to tissues. Sickle cells also break down much faster, surviving only about 10–20 days, resulting in chronic anemia. Blocked blood vessels cause severe pain episodes and damage organs over time. The abnormal shape and reduced lifespan of these cells are the main reasons for the disease's serious symptoms and complications.

6. Symptoms

The symptoms of Sickle Cell Anemia usually begin during early childhood and vary in severity. Common symptoms include chronic anemia, causing tiredness, weakness, and pale skin. Patients often experience painful episodes known as sickle cell crises, resulting from blocked blood vessels. Swelling of the hands and feet, frequent infections, delayed growth and puberty in children, jaundice, and shortness of breath are also common. If left untreated, the disease can damage vital organs such as the heart, lungs, kidneys, and brain. Early diagnosis and proper medical care help reduce symptoms and improve quality of life.

7. Complications

Sickle Cell Anemia can lead to several serious complications if not properly managed. Blocked blood vessels may cause severe pain crises, stroke, acute chest syndrome, and reduced oxygen supply to organs. Long-term complications include kidney disease, liver damage, vision problems, leg ulcers, gallstones, and increased risk of infections due to impaired spleen function. Repeated blockage of blood vessels may result in permanent organ damage and reduced life expectancy. Regular medical care, early treatment, and preventive measures such as vaccination and infection control are essential to reduce complications and improve long-term health outcomes.

8. Diagnosis

Sickle Cell Anemia is diagnosed using laboratory tests that detect abnormal haemoglobin. The most common diagnostic test is haemoglobin electrophoresis, which identifies Haemoglobin S (HbS). Other tests include complete blood count (CBC), peripheral blood smear, genetic testing, and newborn screening programmes. Early diagnosis is important because treatment can begin before severe complications develop. Many countries have introduced newborn screening to identify affected babies soon after birth. Genetic counselling is also recommended for families with a history of the disease. Accurate diagnosis enables timely medical care, monitoring, and preventive treatment.

9. Union Budget 2023–24 Target

The Union Budget 2023–24 announced the Government of India's National Sickle Cell Anaemia Elimination Mission, aiming to eliminate the disease as a public health problem by 2047. The mission focuses on universal screening of vulnerable populations, particularly tribal communities aged 0–40 years. It also promotes early diagnosis, genetic counselling, treatment, awareness campaigns, and better healthcare infrastructure. Digital health records and improved data collection are part of the strategy. This initiative supports India's commitment to reducing the burden of inherited blood disorders and improving healthcare services for affected communities across the country.

10. Way Forward

The effective management of Sickle Cell Anemia requires a comprehensive public health approach. Strengthening screening programmes, especially in tribal and rural areas, is essential for early detection. Public awareness campaigns should educate people about inheritance, prevention, and available treatments. Regular follow-up, vaccination, nutritional support, and access to affordable medicines can significantly improve patient outcomes. Genetic counselling should be provided to at-risk families before marriage or pregnancy. Increased investment in research, stem cell transplantation, gene therapy, and improved healthcare infrastructure will help reduce disease burden. Collaborative efforts can help India achieve the goal of eliminating Sickle Cell Disease by 2047.